文献速递骨质疏松与代谢性骨病骨肿瘤

男性儿童期癌症幸存者低骨密度与性腺功能减退及颅脑放疗相关

Low bone mineral density is associated with hypogonadism and cranial irradiation in male childhood cancer survivors.
PubMed 文献 · Osteoporos Int · 2020-02-01

本研究纳入125例男性儿童期癌症幸存者(CCS)和125例年龄匹配人群对照,检测血清睾酮、黄体生成素及全髋和腰椎L1-L4骨密度(BMD)。整体CCS的BMD与对照无显著差异,但未治疗的性腺功能减退者髋部和脊柱BMD更低且低髋BMD风险升高,既往颅脑放疗者BMD也更低且校正性腺功能减退后仍显著。

要点

  • 未治疗的性腺功能减退男性CCS髋部和脊柱BMD显著低于性腺功能正常者。
  • 未治疗的性腺功能减退者低髋部BMD风险升高(OR 4.1)。
  • 既往颅脑放疗者BMD更低,且独立于性腺功能减退。

核心结论

  • 男性CCS中,未治疗的性腺功能减退或既往颅脑放疗与骨健康受损风险增加相关。
  • 建议在此类男性的随访中考虑骨质疏松预防。

研究设计与样本

  • 研究纳入125例男性CCS(纳入时中位年龄33.7岁,诊断时9.6岁)和125例年龄匹配人群对照。
  • 检测血清睾酮和黄体生成素,测量全髋和腰椎L1-L4的BMD,分析CCS与对照的BMD平均差异(g/cm2;95% CI)及低BMD的OR(95% CI)。

主要发现

  • 整体CCS队列的BMD与对照无显著差异。
  • 与性腺功能正常的CCS相比,未治疗性腺功能减退的CCS髋部BMD平均差异为-0.139(-0.210;-0.067),p<0.001;脊柱为-0.102(-0.174;-0.030),p=0.006。
  • 未治疗性腺功能减退的CCS低髋部BMD的OR为4.1(1.3;14),p=0.018。
  • 与对照相比,接受颅脑放疗的CCS髋部BMD平均差异为-0.076(-0.133;-0.019),p=0.009;脊柱为-0.071(-0.124;-0.018),p=0.009。
  • 颅脑放疗与BMD的关联在校正性腺功能减退后仍具有统计学显著性。

临床怎么用

  • 对男性CCS应关注性腺功能减退,未治疗者需评估骨密度。
  • 有颅脑放疗史的男性CCS应视为骨健康受损高危人群。
  • 随访中应考虑骨质疏松预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We investigated if bone mineral density was related to testosterone deficiency and/or previous cancer treatment in men who were childhood cancer survivors. Men with untreated testosterone deficiency or previous treatment with cranial irradiation were at increased risk of impaired bone health. Prevention of osteoporosis should be considered in their follow-up. INTRODUCTION: Childhood cancer survivors (CCS) are at increased risk of hypogonadism. Reduced bone mineral density (BMD) has been reported in CCS but it is unclear whether this is due to hypogonadism or a direct effect of cancer therapy. This study investigated BMD in CCS, and association with hypogonadism, previous treatment and cancer type. METHODS: Investigation of 125 CCS (median age 33.7 at inclusion; 9.6 at diagnosis) and 125 age-matched population controls. Serum testosterone and luteinizing hormone were assayed and BMD at total hip and lumbar spine L1-L4 measured. The mean difference in BMD (g/cm2; 95% CI) between CCS and controls was analysed. Odds ratios (OR; 95% CI) for low BMD were also calculated. RESULTS: Overall, BMD in the CCS cohort did not significantly differ from controls. However, compared with eugonadal CCS, the CCS with untreated hypogonadism had lower BMD at the hip (mean difference - 0.139 (- 0.210; - 0.067); p < 0.001) and spine (- 0.102 (- 0.174; - 0.030); p = 0.006). They also had a higher risk of low hip BMD (OR 4.1 (1.3; 14); p = 0.018). CCS treated with cranial irradiation also had lower BMD (hip - 0.076 (- 0.133; - 0.019); p = 0.009; spine - 0.071 (- 0.124; - 0.018); p = 0.009) compared with controls. The latter associations remained statistically significant after adjustment for hypogonadism. CONCLUSIONS: CCS with hypogonadism or previously treated with cranial irradiation are at increased risk of impaired bone health. Prevention of osteoporosis should be considered as an important part in future follow-up of these men.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Isaksson S, Bogefors K, Åkesson K, et al. Low bone mineral density is associated with hypogonadism and cranial irradiation in male childhood cancer survivors. Osteoporos Int. 2020. PMID: 32008156. doi:10.1007/s00198-020-05285-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。